Pfizer enters weight loss drug market with Novo Nordisk, Eli Lilly
WEARVALLEYMERCURY

Pfizer enters weight loss drug market with Novo Nordisk, Eli Lilly

CFOTO | Future Publishing | Getty Pictures As its Covid gains evaporate, Pfizer desires a bit of the budding weight loss drug market.  Analysts say upcoming data on Pfizer’s experimental weight problems capsule, danuglipron, shall be essential in figuring out how aggressive the corporate will be towards the area’s dominant gamers Eli Lilly and Novo … Read more

Weight loss drug Wegovy slashes risk of serious heart complications
WEARVALLEYMERCURY

Weight loss drug Wegovy slashes risk of serious heart complications

Nonetheless lifetime of Wegovy an injectable prescription weight reduction drugs that has helped individuals with weight problems. It ought to be used with a weight reduction plan and bodily exercise.  Michael Siluk | UCG | Getty Photographs Novo Nordisk’s Wegovy minimize the danger of great cardiovascular issues in individuals with weight problems and coronary heart … Read more

Many insured U.S. patients pay less than $25 a month
WEARVALLEYMERCURY

Many insured U.S. patients pay less than $25 a month

Nonetheless lifetime of Wegovy an injectable prescription weight reduction medication that has helped folks with weight problems. It must be used with a weight reduction plan and bodily exercise.  Michael Siluk | UCG | Getty Photos Novo Nordisk on Thursday stated 80% of U.S. sufferers with insurance coverage protection who take its extremely standard weight … Read more

Weight-loss drug Wegovy could get new FDA approval in six months
WEARVALLEYMERCURY

Weight-loss drug Wegovy could get new FDA approval in six months

Nonetheless lifetime of Wegovy an injectable prescription weight reduction medication that has helped individuals with weight problems. It must be used with a weight reduction plan and bodily exercise.  Michael Siluk | UCG | Getty Pictures Novo Nordisk stated Thursday that its blockbuster weight-loss drug Wegovy may obtain expanded approval from the U.S. Meals and … Read more

Oil deals and awaiting tech earnings
WEARVALLEYMERCURY

Oil deals and awaiting tech earnings

Merchants work on the ground of the New York Inventory Trade on April 26, 2023 in New York Metropolis.  Michael M. Santiago | Getty Pictures This report is from as we speak’s CNBC Every day Open, our new, worldwide markets e-newsletter. CNBC Every day Open brings buyers in control on every thing they should know, … Read more

Wall Street hikes forecast for anti-obesity drug sales to $100 billion
WEARVALLEYMERCURY

Wall Street hikes forecast for anti-obesity drug sales to $100 billion

Most analysts predict the marketplace for new weight reduction medicine comparable to Wegovy and Mounjaro might be monumental, however estimates fluctuate for its precise dimension relying on who you ask. On Monday, Citi raised its estimate for incretin drug gross sales to $71 billion by 2035, up from its prior estimate of $55 billion. That … Read more

Novo Nordisk hikes outlook on soaring demand for Wegovy, Ozempic
WEARVALLEYMERCURY

Novo Nordisk hikes outlook on soaring demand for Wegovy, Ozempic

Novo Nordisk on Friday raised its outlook for its full-year gross sales and working revenue attributable to hovering demand for its blockbuster weight reduction drug Wegovy and diabetes remedy Ozempic.  The revised forecast solely confirms the frenzy for these weekly injections, which sufferers search for his or her potential to assist them lose vital weight … Read more

LVMH falls to 2023 low as growth slows, pulling luxury sector lower
WEARVALLEYMERCURY

LVMH falls to 2023 low as growth slows, pulling luxury sector lower

A LVMH Moet Hennessy Louis Vuitton SE retailer in Shanghai, China on Wednesday, June 14, 2023. Bloomberg | Bloomberg | Getty Photos Shares of LVMH dropped to their lowest degree of the 12 months on Wednesday morning, after the corporate reported a slowdown in income development that was beneath expectations. The inventory was down 6% … Read more